Review Journal of Autism and Developmental Disorders, published by Springer Heidelberg, stands as a leading platform for the dissemination of groundbreaking research in the realm of autism and developmental disorders. With an ISSN of 2195-7177 and an E-ISSN of 2195-7185, this journal not only showcases high-quality research but also emphasizes the crucial intersections between behavioral neuroscience, cognitive neuroscience, developmental neuroscience, and psychiatry. Notably, the journal has achieved a prestigious Q1 ranking across these categories, reflecting its impact and relevance; it ranks 10th in behavioral neuroscience and 5th in developmental neuroscience within Scopus metrics. Spanning from 2014 to 2024, the journal is dedicated to fostering a deeper understanding of autism spectrum disorders and related conditions, making it indispensable for researchers, clinicians, and students alike. While it operates under a traditional access model, the quality of the peer-reviewed articles ensures that it remains a valuable resource in the academic community.

NEUROPHARMACOLOGY, published by PERGAMON-ELSEVIER SCIENCE LTD, is a prestigious journal in the field of neuroscience and pharmacology, with a distinguished history dating back to 1962. With an ISSN of 0028-3908 and an E-ISSN of 1873-7064, the journal serves as a dynamic platform for the latest research that explores the intricate relationships between pharmacological agents and neural processes. Positioned in the Q1 quartile in both Cellular and Molecular Neuroscience and Pharmacology, it is recognized for its significant impact in the scientific community, boasting Scopus rankings of #36 in Pharmacology and #16 in Cellular and Molecular Neuroscience, underscoring its excellence and relevance. Although not an open access publication, its contributions are pivotal for researchers, professionals, and students sought to understand the complexities of neuropharmacological interactions. The journal aims to disseminate groundbreaking research findings, reviews, and perspectives that expand the frontiers of knowledge in the fields, making it an essential resource for anyone involved in neuroscience and pharmacology research.

NEUROBIOLOGY OF DISEASE is a premier journal dedicated to advancing the understanding of neurological disorders and the underlying biological processes, published by Academic Press Inc, Elsevier Science. With an impressive impact factor indicative of its significance—ranked in the Q1 quartile in Neurology for 2023 and occupying the 14th rank out of 192 journals in the field of Neuroscience and Neurology—this journal serves as a critical resource for researchers, clinicians, and students alike. The journal has a rich history since its inception in 1994, continuously evolving its scope to encompass groundbreaking research and insights into neurobiological mechanisms and disease pathology. Though it currently does not provide Open Access options, NEUROBIOLOGY OF DISEASE remains a vital vessel for disseminating knowledge that significantly contributes to the field of neurology, fostering an understanding that can lead to innovative therapeutic strategies.

NeuroSci is an esteemed open-access journal published by MDPI, dedicated to advancing the field of neuroscience through high-quality research dissemination. Operating under the E-ISSN 2673-4087, this journal aims to foster collaboration and innovation by providing a platform for original research articles, reviews, and theoretical studies that address the complexities of the brain and nervous system. NeuroSci encourages submissions from a wide array of disciplines including cognitive neuroscience, neurobiology, neurophysiology, and neuropsychology, making it an essential resource for researchers, professionals, and students alike. With its commitment to open accessibility, NeuroSci ensures that groundbreaking findings are readily available to the global community, thereby enhancing the impact and exchange of knowledge in neuroscience. The journal is located at ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, contributing to the reputation of MDPI as a leading publisher in the academic landscape.

PROGRESS IN NEUROBIOLOGY is a prestigious journal dedicated to advancing the field of neuroscience, published by Pergamon-Elsevier Science Ltd. With an impressive impact factor, it stands as a critical resource for researchers, professionals, and students alike, featuring rigorous peer-reviewed articles that explore the latest developments in neurobiology. The journal has established itself as a leading publication, ranked in the Q1 category for Neuroscience (miscellaneous) and holding a notable 13/113 rank in General Neuroscience per Scopus metrics, placing it in the top 12% of its field. Since its inception in 1959, PROGRESS IN NEUROBIOLOGY has covered a wide array of topics, from molecular mechanisms to cognitive processes, fostering a comprehensive understanding of brain functions. While the journal is not open access, it ensures accessibility to profound knowledge through institutional subscriptions. Researchers and scholars will find critical analyses and innovative research that are pivotal for both foundational knowledge and cutting-edge investigations in the neuroscience realm.

CORTEX is a premier international journal published by Elsevier Masson, focusing on the cutting-edge areas of cognitive neuroscience, psychology, and neurology. With an impressive impact factor that places it in Q1 quartiles across multiple categories such as Cognitive Neuroscience and Neuropsychology, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 1964, CORTEX has continued to excel in disseminating high-quality scholarly work, offering insights that significantly enhance our understanding of the brain's functioning and behavior. Although not an open-access publication, it provides various access options to ensure the dissemination of knowledge is as wide-reaching as possible. As the field of cognitive psychology evolves, CORTEX remains at the forefront, fostering an environment for interdisciplinary collaboration and innovation. Researchers seeking to stay engaged with the latest advancements will find CORTEX an indispensable tool for their professional development.

IBRO Neuroscience Reports, published by Elsevier, is a pivotal open-access journal dedicated to advancing the field of neuroscience. With its ISSN 2667-2421, the journal serves as a vital platform for researchers, professionals, and students alike, showcasing innovative research and interdisciplinary studies that span various aspects of neuroscience. Since its inception in 2021, and with a planned convergence through 2024, the journal has quickly established itself within the academic community, currently holding a Q3 category ranking in the field of Neuroscience (miscellaneous) and a Scopus rank of #77 among 113 in General Neuroscience, reflecting its ongoing commitment to quality and relevance. The accessibility of research articles ensures that critical findings are widely disseminated, fostering collaboration and dialogue within the neuroscientific community. Researchers and professionals are encouraged to contribute to this dynamic journal, reinforcing its role in shaping the future of neuroscience research.

BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

NeuroImage-Clinical is a premier open access journal published by Elsevier Science Ltd, dedicated to advancing the field of clinical neuroimaging and its applications in a variety of neurological disorders. With an ISSN of 2213-1582, this journal has established itself as a leading source of innovative research since its inception in 2012, now continuing through 2024. Recognized for its high impact, it occupies the top quartile (Q1) in prestigious categories such as Cognitive Neuroscience, Neurology, and Radiology, affirming its relevance in clinical and research settings. Its Scopus rankings further exemplify its significant contribution to the disciplines of Radiology and Neurology, consistently placing it among the top tiers of journals in these fields. This journal not only provides critical insights for researchers and professionals but also serves as a valuable resource for students, fostering an understanding of the complexities in neuroimaging techniques and their implications for patient care. With open access options ensuring broad dissemination of knowledge, NeuroImage-Clinical plays a pivotal role in enhancing collaboration and innovation within the global neuroscience community.